HBImed

HBimed operates within the specialized neurotechnology and digital health sector, focusing on quantitative electroencephalography (QEEG) and brain diagnostics. The company differentiates itself through its proprietary HBI methodology, which uniquely integrates both spectral data and high signal-to-noise-ratio evoked-potential data into a unified normative database. While broader digital health and neuro-diagnostic markets feature various competitors offering EEG analysis software, HBimed's specific emphasis on mapping information flow within the working brain positions it as a targeted provider for clinical neurology, psychiatry, and specialized mental health practices.

HBimed has established a steady operational footprint centered on clinical training, normative database licensing, and QEEG software tools. Growth has been driven organically through adoption by healthcare professionals utilizing its diagnostic workflows rather than through large-scale, venture-backed funding cycles. The company sustains its development by continuously updating its normative databases and expanding educational offerings for practitioners seeking to incorporate advanced quantitative EEG metrics into clinical practice.